Ever since I got back to France a couple of weeks ago, two hotly debated news stories have caught my attention. What I love about the French is that they take the gloves off when it comes to discussing issues, and listening to both sides has been rather fascinating. One of these issues is the “debat sur l’identite nationale” (“debate on national identity”), which is an attempt by the Minister of Immigration, Integration, National Identity and Solidary Development (a real mouthful) to (re)define the tenets of French national identity. That’ll be the topic of another post. For now, suffice it to say that it’s highly contentious and has opened the door and given credence to racist and intolerant comments in the media and the political arena.
The other issue that I’ve been following with a lot of curiosity is the kerfuffle around H1N1. After having spent two months in Liberia where H1n1 is not at all discussed, I came back to a country where the Minister of Health, Roselyne Bachelot, had made the decision to purchase 94 million doses of Tamiflu to innoculate the French population. First of all, given that there are only 63 million citizens, the 94 million figure seems excessive. Apparently, the French authorities were told that those who get vaccinated must get more than one shot, hence the incredibly large order of Tamiflu – except that, oops!, you actually only need one dose. France has apparently purchased 1/3 (one third!) of all Tamiflu stocks in the world, for a mere 870 million euros (1,250,000,000 USD). Now, the French are trying to cancel part of their order to four different pharmaceutical companies, hoping to save 350 million euros. The government is also selling off their overstock abroad – but given that the epidemic’s peak has apparently been reached, they are having a hard time finding customers for their second hand vaccine.
The government has come under fire for inflating the threat posed by H1N1, and responding inappropriately. Many opposition figures are calling the government’s handling of H1N1 “scandalous” and a waste of public funds. Sarkozy’s Foreign Affairs Minister, loud-mouthed Bernard Kouchner, claims that he is “scandalized by the scandal”, and that if the government had not taken the epidemic seriously and people had died of H1N1, then the criticism would have been (legitimately) much stronger. President Nicolas Sarkozy defended the Health Minister’s decision by saying that 219 people died of this flu in 2009, and that his government couldn’t make it a banal issue. Fair enough. But let’s do some simple math. First of all, 94 million vaccines for 870 million euros is unbelievably expensive – nearly 10 euros (15 USD) per dose. Really?! What’s the production cost of this vaccine? And if it’s critical to global public health, shouldn’t the pharmas make it slightly more affordable? (I know the answer to that question – I mean it rhetorically). Alternatively, couldn’t France have negotiated these prices a little bit more? Sweet deal for the pharmas.
219 deaths from H1N1 in 2009….and between 1,500 and 2,000 deaths from the “regular” flu every year, in France. 2.5 million people suffer from the flu each year in the country. In fact, the flu is the number one infectious disease in France. Now, are we spending even a fraction of what we’re spending on H1N1 to fight the “regular” flu? No. I honestly have no idea how the government can justify spending nearly one billion euros on this new strain of flu. The flu is a perennial disease, and it’s a constantly evolving infection. Perhaps we should spend a fraction of the 870 million euros on strengthening health systems, particularly prevention activities among the vulnerable: the young, the elderly, pregnant women and (gasp!) poor people.
Each year in France, HIV-AIDS kills 1,700 people and there are more than 5,000 new infections. Why aren’t we spending hundreds of millions of euros stopping the spread of this incurable disease? Infectious disease causes only 2% of deaths in France – why not focus on the real killers?
A recent motion in the European Parliament reads:
“In order to promote their patented drugs and vaccines against flu, pharmaceutical companies have
influenced scientists and official agencies, responsible for public health standards, to alarm governments
worldwide. They have made them squander tight health care resources for inefficient vaccine strategies and
needlessly exposed millions of healthy people to the risk of unknown side-effects of insufficiently tested
The “birds-flu“-campaign (2005/06) combined with the “swine-flu“-campaign seem to have caused a great
deal of damage not only to some vaccinated patients and to public health budgets, but also to the credibility
and accountability of important international health agencies. The definition of an alarming pandemic must
not be under the influence of drug-sellers.
The member states of the Council of Europe should ask for immediate investigations on the consequences at national as well as European level.”